adenosine has been researched along with Osteosarcoma in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 12 (63.16) | 2.80 |
| Authors | Studies |
|---|---|
| Heitman, LH; IJzerman, AP; Vlachodimou, A | 1 |
| Quan, H; Wang, J; Xu, K; Zhang, J; Zhang, P | 1 |
| Chen, D; Deng, Y; Li, Z; Wang, J; Wu, X; Wu, Z; Zhang, X | 1 |
| Chen, Y; He, J; Lin, H; Miao, L; Zhuo, Z | 1 |
| Gao, Y; Qu, YX; Wang, B; Wei, K | 1 |
| Chen, HL; Duan, G; Gu, WX; Shan, HJ | 1 |
| Bao, X; Cai, Z; Luo, Z; Yang, C; Yang, Z | 1 |
| Chen, S; Deng, Y; Hu, M; Huang, L; Jing, S; Li, J; Li, Y; Liu, T; Miao, J; Peng, Y; Wang, D; Wang, S; Wang, W; Xu, D; Yan, Z; Yu, H; Zeng, J; Zhang, A; Zhao, X; Zhou, Z | 1 |
| Han, J; Kong, H; Wang, X; Zhang, XA | 1 |
| Bao, Y; Chen, B; He, M; Lu, J; Luo, Y; Qiu, G; Wang, Y; Xu, J; Xu, Y; Zhang, Y | 1 |
| Dong, Y; Ji, W; Liang, C; Tu, S; Wang, Y; Wei, Y; Zan, R; Zeng, L; Zhang, Z | 1 |
| Chen, L; Ling, Z; Zhao, J | 1 |
| Lin, F; Lu, H; Qian, G; Shen, Z; Sun, Y; Wang, J; Yu, W; Zhang, Z; Zheng, S; Zhou, C; Zhou, Y; Zhu, X | 1 |
| Wang, L; Zhang, P; Zhang, Q; Zhang, W | 1 |
| Chen, J; Jia, L; Ma, J; Miao, W; Song, D | 1 |
| Clemens, D; Dirksen, U; Hotfilder, M; Klco-Brosius, S; Pettke, A; Potratz, J; Schaefer, C | 1 |
| Cai, ZD; Chen, F; Hua, YQ; Sun, TW; Tan, J; Wang, HS; Zhou, ZF; Zuo, DQ | 1 |
| Park, JA; Shin, HY | 1 |
| Benton, HP; Russell, JM; Stephenson, GS; Yellowley, CE | 1 |
3 review(s) available for adenosine and Osteosarcoma
| Article | Year |
|---|---|
The role of m6A modification in pediatric cancer.
Topics: Adenosine; Bone Neoplasms; Child; Epigenesis, Genetic; Humans; Osteosarcoma; RNA, Messenger | 2022 |
Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders.
Topics: Adenosine; Bone Neoplasms; Humans; Intervertebral Disc Degeneration; Methylation; MicroRNAs; Osteoarthritis; Osteoporosis; Osteosarcoma; RNA, Circular; RNA, Long Noncoding; RNA, Untranslated | 2022 |
N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
Topics: Adenosine; Adolescent; Bone Neoplasms; Child; DNA Methylation; Humans; MicroRNAs; Osteosarcoma; RNA, Untranslated; Tumor Microenvironment | 2023 |
16 other study(ies) available for adenosine and Osteosarcoma
| Article | Year |
|---|---|
Label-free detection of transporter activity via GPCR signalling in living cells: A case for SLC29A1, the equilibrative nucleoside transporter 1.
Topics: Cell Line, Tumor; Equilibrative Nucleoside Transporter 1; Humans; Ligands; Membrane Transport Proteins; Osteosarcoma; Receptors, G-Protein-Coupled; Receptors, Purinergic P1; Signal Transduction | 2019 |
Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma.
Topics: Adenosine; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Humans; Osteosarcoma; Proportional Hazards Models; Risk Factors; RNA, Long Noncoding; Survival Rate; Up-Regulation | 2021 |
N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Topics: Adenosine; Biomarkers, Tumor; Computational Biology; Databases, Genetic; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lymphocytes, Tumor-Infiltrating; Methylation; Osteosarcoma; Prognosis; RNA, Long Noncoding; ROC Curve; Transcriptome; Tumor Microenvironment | 2021 |
Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
Topics: Adenosine; Bone Neoplasms; Cell Proliferation; Exoribonucleases; Humans; Methylation; Methyltransferases; Osteosarcoma; Receptors, CCR4; Repressor Proteins; RNA-Binding Proteins; RNA, Messenger | 2022 |
Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Krüppel-like factor 3 (KLF3) promotes osteosarcoma progression.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Bone Neoplasms; Humans; Kruppel-Like Transcription Factors; Osteosarcoma; RNA, Messenger | 2022 |
ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Bone Neoplasms; Cell Proliferation; Humans; Osteosarcoma; RNA; RNA-Binding Proteins; RNA, Messenger; STAT3 Transcription Factor | 2022 |
RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma.
Topics: Adenosine; Biomarkers, Tumor; Bone Neoplasms; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Osteosarcoma; Prognosis; RNA; Strophanthidin | 2022 |
Integrated analysis of transcriptome-wide m
Topics: Adenosine; Bone Neoplasms; Cell Line, Tumor; Epigenesis, Genetic; Epigenome; Gene Expression Profiling; Humans; Methylation; Neoplastic Stem Cells; Osteosarcoma; RNA; Transcriptome | 2019 |
m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.
Topics: Adenosine; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Computational Biology; DNA Methylation; ELAV-Like Protein 1; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; GTP-Binding Proteins; Humans; Male; Methyltransferases; Osteosarcoma; Up-Regulation; Young Adult | 2020 |
N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1.
Topics: Adenosine; Adolescent; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinogenesis; Cell Line, Tumor; Child; Chromatography, Liquid; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mass Spectrometry; Mice; Neoplasm Staging; Osteosarcoma; Prognosis; Protein Binding; Repressor Proteins; Tripartite Motif Proteins; Ubiquitin-Protein Ligases; Ubiquitination | 2020 |
m6A regulators are associated with osteosarcoma metastasis and have prognostic significance: A study based on public databases.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Biomarkers, Tumor; Datasets as Topic; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Methylation; Methyltransferases; Nerve Tissue Proteins; Osteosarcoma; Prognosis; Proportional Hazards Models; RNA Splicing Factors; RNA-Seq | 2021 |
The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
Topics: Adenosine; Adolescent; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Child; Disease Progression; Humans; Lymphoid Enhancer-Binding Factor 1; Methylation; Methyltransferases; Osteosarcoma; RNA Interference; RNA, Messenger; Wnt Signaling Pathway | 2019 |
Suberanilohydroxamic acid (vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines.
Topics: Adenosine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Neoplasms; Cell Growth Processes; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Osteosarcoma; Vorinostat | 2016 |
Calcium phosphate-phosphorylated adenosine hybrid microspheres for anti-osteosarcoma drug delivery and osteogenic differentiation.
Topics: Absorbable Implants; Adenosine; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Calcium Phosphates; Capsules; Cell Differentiation; Cell Line, Tumor; Doxorubicin; Female; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Osteoblasts; Osteogenesis; Osteosarcoma; Phosphorylation; Porosity; Treatment Outcome | 2017 |
ATIC Gene Polymorphism and Histologic Response to Chemotherapy in Pediatric Osteosarcoma.
Topics: Adenosine; Adolescent; Antineoplastic Agents; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Hydroxymethyl and Formyl Transferases; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Multienzyme Complexes; Nucleotide Deaminases; Osteosarcoma; Polymorphism, Single Nucleotide; Reduced Folate Carrier Protein; Survival Rate; Tetrahydrofolate Dehydrogenase | 2017 |
Adenosine inhibition of lipopolysaccharide-induced interleukin-6 secretion by the osteoblastic cell line MG-63.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Cell Line, Tumor; Colforsin; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Humans; Interleukin-6; Lipopolysaccharides; Osteoblasts; Osteosarcoma; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Time Factors | 2007 |